Filtros de búsqueda

Lista de obras de

'New/Designer Benzodiazepines': an analysis of the literature and psychonauts' trip reports

scientific article published on 10 January 2020

A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database

artículo científico publicado en 2016

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.

artículo científico publicado en 2018

An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions

artículo científico publicado en 2019

Assessing the 2004-2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems

scientific article published on 01 February 2019

COVID-19: The Hidden Impact on Mental Health and Drug Addiction

scientific article published on 29 July 2020

Cannabidiol (CBD) use in psychiatric disorders: A systematic review

scientific article published on 11 August 2019

Climate change, biodiversity loss and mental health: a global perspective

scientific article published in 2022

Deaths of individuals aged 16-24 years in the UK after using mephedrone

artículo científico publicado en 2015

Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database

artículo científico publicado en 2020

How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy

scientific article published on 27 March 2020

Is There a Potential of Misuse for Venlafaxine and Bupropion?

artículo científico publicado en 2018

Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports

scientific article published in PLoS ONE

Methoxetamine-related deaths in the UK: an overview.

artículo científico publicado en 2015

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FA

artículo científico publicado en 2022

Pregabalin: A range of misuse-related unanswered questions

scientific article published on 04 March 2019

The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective

scientific article published on 20 November 2019

The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review

scientific article published on 24 September 2019

Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review

scientific article published on 23 August 2019

What about "Pharming"? Issues Regarding the Misuse of Prescription and Over-the-Counter Drugs

artículo científico publicado en 2020

β-2 Agonists as Misusing Drugs? Assessment of both Clenbuterol- and Salbutamol-related European Medicines Agency Pharmacovigilance Database Reports

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda